| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.600 | None | 0.950 | 519 | 10 | 1990 | 2019 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
disease | 0.500 | None | 0.979 | 266 | 8 | 1984 | 2020 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
disease | 0.700 | None | 0.960 | 230 | 0 | 1994 | 2020 | ||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
disease | 0.100 | None | 0.944 | 126 | 0 | 1996 | 2020 | |||||||||
|
CD274 molecule | 0.324 | 0.923 | 1.9E-02 |
|
disease | 0.100 | None | 0.935 | 92 | 0 | 2003 | 2020 | ||||||||
|
tumor protein p63 | 0.362 | 0.769 | 1.00 |
|
disease | 0.400 | None | 0.963 | 76 | 1 | 2001 | 2020 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
disease | 0.400 | None | 0.988 | 74 | 0 | 1989 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.400 | None | 1.000 | 67 | 3 | 2001 | 2020 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.400 | None | 0.987 | 59 | 0 | 1997 | 2019 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
disease | 0.100 | None | 0.983 | 58 | 0 | 1982 | 2019 | ||||||||
|
cytoskeleton associated protein 4 | 0.436 | 0.731 | 0.51 |
|
disease | 0.100 | None | 0.965 | 56 | 0 | 2001 | 2019 | ||||||||
|
retinoid isomerohydrolase RPE65 | 0.417 | 0.808 | 6.5E-14 |
|
disease | 0.100 | None | 0.964 | 56 | 0 | 2001 | 2019 | ||||||||
|
UV radiation resistance associated | 0.436 | 0.769 | 0.99 |
|
disease | 0.100 | None | 0.964 | 55 | 0 | 2001 | 2019 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.400 | None | 0.972 | 55 | 1 | 1996 | 2019 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.300 | None | 0.869 | 53 | 0 | 1994 | 2019 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
disease | 0.100 | None | 0.965 | 50 | 0 | 1990 | 2019 | ||||||||
|
SRY-box transcription factor 2 | 0.405 | 0.808 | 0.71 |
|
disease | 0.400 | None | 1.000 | 41 | 0 | 2009 | 2019 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0.978 | 40 | 0 | 2003 | 2019 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.400 | None | 1.000 | 38 | 2 | 1985 | 2019 | ||||||||
|
glutathione S-transferase mu 1 | 0.380 | 0.923 | 2.1E-03 |
|
disease | 0.400 | None | 0.927 | 37 | 0 | 1993 | 2015 | ||||||||
|
CD44 molecule (Indian blood group) | 0.363 | 0.962 | 2.4E-07 |
|
disease | 0.100 | None | 0.951 | 37 | 1 | 1995 | 2019 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.100 | None | 0.947 | 36 | 1 | 1998 | 2019 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.600 | None | 1.000 | 34 | 0 | 1986 | 2016 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
disease | 0.100 | None | 1.000 | 34 | 1 | 2002 | 2019 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
disease | 0.400 | None | 0.976 | 34 | 0 | 2002 | 2020 |